Madhav Rajan - IShares Global Independent Trustee
| IXJ Etf | USD 90.16 0.40 0.45% |
Mr. Madhav V. Rajan is an Independent Trustee of iShares Global Healthcare ETF. Mr. Rajan has served as a Director of iShares, Inc. and a Director of iShares MSCI Russia Capped Index Fund, Inc. since 2011. Mr. Rajan is the Gregor G. Peterson Professor of Accounting at the Stanford Graduate School of Business. He has taught accounting for 20 years to undergraduate, MBA and law students, as well as to senior executives. Mr. Rajan serves as the Senior Associate Dean for Academic Affairs and head of the MBA Program at the Stanford Graduate School of Business. Mr. Rajan served as editor of The Accounting Review from 2002 to 2008 and is coauthor of Cost Accounting A Managerial Emphasis, a cost accounting textbook
| Age | 52 |
| Tenure | 13 years |
| Professional Marks | MBA |
| Web | http://www.ishares.com/us/products/239744/ishares-global-healthcare-etf |
| Issuer | iShares |
| Inception Date | 2001-11-13 |
| Benchmark | S&P Global 1200 Healthcare Sector Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 3.9 Billion |
| Average Trading Valume | 155,379.5 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Blended Development |
IShares Global Management Efficiency
The company has Return on Asset of 0.88 % which means that on every $100 spent on assets, it made $0.88 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 23.19 %, implying that it generated $23.19 on every 100 dollars invested. IShares Global's management efficiency ratios could be used to measure how well IShares Global manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Robert Kapito | iShares Healthcare ETF | 62 | |
| Eilleen Clavere | iShares Global Financials | 60 | |
| Cecilia Herbert | iShares Global Financials | 67 | |
| Robert Kapito | iShares Global Financials | 61 | |
| John Martinez | iShares Global Financials | 55 | |
| Patrick OConnor | iShares Global Comm | 48 | |
| Cecilia Herbert | iShares Healthcare ETF | 67 | |
| Charles Hurty | iShares Global Financials | 72 | |
| John Martinez | iShares Global Energy | 55 | |
| Robert Silver | iShares Global Energy | 57 | |
| Robert Silver | iShares Healthcare ETF | 57 | |
| Eilleen Clavere | iShares Healthcare ETF | 60 | |
| Charles Hurty | iShares Healthcare ETF | 72 | |
| John Kerrigan | iShares Healthcare ETF | 60 | |
| Charles Hurty | iShares Global Energy | 72 | |
| Cecilia Herbert | iShares Global Energy | 67 | |
| John Kerrigan | iShares Global Energy | 60 | |
| John Martinez | iShares Healthcare ETF | 55 | |
| Patrick OConnor | iShares Global Tech | 48 | |
| Robert Silver | iShares Global Financials | 57 | |
| Eilleen Clavere | iShares Global Energy | 60 | |
Management Performance
| Return On Equity | 23.19 | |||
| Return On Asset | 0.88 |
iShares Global Healthcare Money Managers
| Robert Silver, Independent Chairman of the Board of the Trustee | ||
| John Kerrigan, Independent Trustee | ||
| Madhav Rajan, Independent Trustee | ||
| Cecilia Herbert, Independent Trustee | ||
| Michael Latham, President Trustee | ||
| Jack Gee, Chief Financial Officer, Treasurer | ||
| Charles Hurty, Independent Trustee | ||
| Edward Baer, Vice President Chief Legal Officer | ||
| Eilleen Clavere, Secretary | ||
| Scott Radell, Executive Vice President | ||
| George Parker, Independent Trustee | ||
| John Martinez, Independent Trustee | ||
| Amy Schioldager, Executive Vice President | ||
| Robert Kapito, Trustee | ||
| Ira Shapiro, Vice President |
IShares Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IShares Global a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 23.19 | |||
| Return On Asset | 0.88 | |||
| Operating Margin | 76.50 % | |||
| Current Valuation | 3.06 B | |||
| Shares Outstanding | 35.85 M | |||
| Shares Owned By Institutions | 72.32 % | |||
| Price To Earning | 5.54 X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 73.93 X | |||
| Revenue | 43.28 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Global Healthcare. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
The market value of iShares Global Healthcare is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Global's value that differs from its market value or its book value, called intrinsic value, which is IShares Global's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Global's market value can be influenced by many factors that don't directly affect IShares Global's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Global's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Global is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Global's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.